Recent Finacing
Recent Raise
Imophoron develops the ADDomer thermotolerant self-assembling protein vaccine platform enabling rapid multiepitope display, and conducts preclinical efficacy, immunogenicity, safety, cell-line establishment, manufacturing scale-up and toxicology studies.
